Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status CTKB Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen AVIR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment CCEP Q4 2018 Earnings Slight EPS Miss Highlights Cost Pressures Versus Systems Inc Q4 2025 Earnings Continued Losses Amid Restructuring Efforts Indias REITs May Offer Retail Investors a New Avenue for Wealth Creation NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction